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Abstract
Trypanosoma brucei is the causative agent of humanAfrican sleeping sickness and the cattle disease
nagana. Trypanosoma brucei is dependent on glycoproteins for its survival and infectivity through-
out its life cycle. Here we report the functional characterization of TbGT3, a glycosyltransferase ex-
pressed in the bloodstream and procyclic form of the parasite. Bloodstream and procyclic form
TbGT3 conditional null mutants were created and both exhibited normal growth under permissive
and nonpermissive conditions. Under nonpermissive conditions, the normal glycosylation of the
major glycoprotein of bloodstream form T. brucei, the variant surface glycoprotein and the absence
of major alterations in lectin binding to other glycoproteins suggested that the major function of
TbGT3 occurs in the procyclic form of the parasite. Consistent with this, the major surface glycopro-
tein of the procyclic form, procyclin, exhibited a marked reduction in molecular weight due to
changes in glycosylphosphatidylinositol (GPI) anchor side chains. Structural analysis of the mutant
procyclin GPI anchors indicated that TbGT3 encodes a UDP-Gal: β-GlcNAc-GPI β1-3 Gal transferase.
Despite the alterations in GPI anchor side chains, TbGT3 conditional null mutants remained infec-
tious to tsetse ﬂies under nonpermissive conditions.
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Introduction
The tsetse-transmitted Trypanosoma brucei group of parasites cause
Human African Trypanosomiasis and nagana in cattle and constitute
a serious health problem for people and livestock in 36 countries of
sub-Saharan Africa. Trypanosoma brucei exists in the mammalian
host as the bloodstream form trypomastigote and in the midgut of
the tsetse ﬂy vector (Glossina sp.) as the procyclic form. The blood-
stream form of the parasite in the mammalian host is covered by a
glycosylphosphatidylinositol (GPI)-anchored coat of 5 × 106 variant
surface glycoprotein (VSGs) homodimers and it evades the immune
system by periodically replacing the existing VSG coat by a different
one, a phenomenon known as antigenic variation (Cross 1996). De-
pending on the VSG variant GPI anchors contain side chains of 0–6
Gal residues (Ferguson et al. 1988) and between 1 and 3 N-linked gly-
cans. The latter can be of the conventional oligomannose, pauciman-
nose or complex types (Zamze et al. 1990, 1991; Jones et al. 2005;
Manthri et al. 2008; Izquierdo, Schulz, et al. 2009).
When bloodstream form parasites are ingested by the tsetse ﬂy,
they differentiate to the procyclic form in the insect midgut. During
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this process, the VSG coat is replaced by a mix of GPI-anchored pro-
cyclins, a non-GPI surface coat (Guther et al. 2006) as well as free GPIs
(Lillico et al. 2003; Vassella et al. 2003; Nagamune et al. 2004; Roper
et al. 2005). Procyclins are characterized by internal dipeptide (EP) or
pentapeptide (GPEET) repeats which confer a rod-like structure to the
protein (Roditi et al. 1989; Treumann et al. 1997).
Trypanosoma brucei strain 427, the strain used in this study, con-
tains (per diploid genome): two copies of the GPEET1 gene encoding
six GPEET repeats; one copy each of the EP1-1 and EP1-2 genes, en-
coding EP1 procyclins with 30 and 25 EP repeats, respectively; two
copies of the EP2-1 gene, encoding EP2 procyclin with 25 EP repeats;
and two copies of the EP3-1 gene, encoding EP3 procyclin with 22 EP
repeats (Acosta-Serrano et al. 1999). The EP1 and EP3 procyclins con-
tain a single N-glycosylation site, occupied exclusively by a conven-
tional triantennary oligomannnose Man5GlcNAc2 oligosaccharide,
at the N-terminal side of the EP repeat domain (Treumann et al.
1997; Acosta-Serrano et al. 1999). Either EP2 or GPEET procyclins
are N-glycosylated and GPEET1 procyclin is phosphorylated on six
of seven Thr residues (Mehlert et al. 1999; Schlaeppi et al. 2003).
Both GPEET and EP procyclins contain indistinguishable GPI mem-
brane anchors. These are the largest and most complex anchors
known and they are characterized by the presence of large
poly-disperse-branched N-acetyllactosamine (Galβ1-4GlcNAc) and
lacto-N-biose (Galβ1-3GlcNAc)-containing side chains that can be
capped with α2-3-linked sialic acid residues (Ferguson et al. 1993;
Treumann et al. 1997). Sialic acids are transferred from serum sialo-
glycoconjugates to terminal β-galactose residues by the action of a cell
surface trans-sialidase enzyme (Engstler et al. 1993; Pontes de Carval-
ho et al. 1993; Montagna et al. 2002, 2006) and trans-sialylation of
surface components plays a role in the successful colonization of the
tsetse ﬂy (Nagamune et al. 2004). In addition, it has been postulated
that the branched side chains of the anchor form a dense glycocalyx
that contributes to the protective function of the coat against digestive
enzymes in the ﬂy midgut (Acosta-Serrano et al. 2001).
As well as the aforementioned major GPI-anchored surface mole-
cules, T. brucei expresses numerous other GPI-anchored and trans-
membrane glycoproteins at the cell surface, in the ﬂagellar pocket
and in the intracellular endosomal–lysosomal system, some of which
are lifecycle stage- or display lifecycle stage-speciﬁc glycosylation dif-
ferences. For example, the transmembrane invariant surface glycopro-
teins ISG65 and ISG75 (Ziegelbauer and Overath 1992) and the
GPI-anchored ﬂagellar pocket ESAG6/ESAG7 heterodimeric transfer-
rin receptors (Steverding et al. 1995; Steverding 2000; Mehlert and
Ferguson 2007; Mehlert et al. 2012) are speciﬁc to the bloodstream
lifecycle stage while the major lysosomal glycoprotein is common to
bloodstream and procyclic stages but contains complex N-glycans
only in the bloodstream stage (Kelley et al. 1995). This control of
stage-speciﬁc glycosylation probably resides primarily at the level of
oligosaccharyltransferase expression (Izquierdo, Schulz, et al. 2009).
The survival strategies of protozoan parasites frequently involve the
participation of glycoconjugates. Trypanosoma brucei expresses many
glycoproteins containing Gal and GlcNAc, including glycoproteins
with novel bloodstream form-speciﬁc giant poly-N-acetyllactosamine
(poly-LacNAc) containing N-linked glycans (Mehlert, Richardson,
et al. 1998; Mehlert, Zitzmann, et al. 1998; Atrih et al. 2005). The cre-
ation of UDP-glucose 4′-epimerase (TbGalE) conditional null mutants
showed that this gene, and hence UDP-Gal, is essential for the survival
of the parasite in both the bloodstream and procyclic life stages (Roper
et al. 2002; Roper et al. 2005; Urbaniak et al. 2006). Similarly, the cre-
ation of UDP-GlcNAc pyrophosphorylase (TbUAP) and glucosamine
6-phosphate N-acetyltransferase (TbGNA1) conditional null mutants
has shown that UDP-GlcNAc is also essential for bloodstream form
T. brucei (Marino et al. 2011; Stokes et al. 2008). From these experi-
ments, it is possible to conclude that one or more of the UDP-
Gal- and UDP-GlcNAc-dependent glycosylation pathways are essential
to the parasite. This has provided the impetus to identify and character-
ize the UDP-Gal and UDP-GlcNAc-dependent glycosyltransferase (GT)
genes in the parasite. In a recent study, we mined the T. brucei genome
for GTs and found a family of 21 genes with predicted amino acid
sequences consistent with being UDP-sugar-dependent GTs.
The ﬁrst of these genes to be studied were TbGT8, a UDP-GlcNAc:
βGal β1-3 GlcNAc-transferase that modiﬁes the complex GPI anchor
side chains of the procyclins (Izquierdo, Nakanishi, et al. 2009) and
also elaborates complex N-glycans in bloodstream from parasites
(Nakanishi et al. 2014), and TbGT11, a UDP-GlcNAc:αMan β1-2
GlcNAc-transferase equivalent to GnTI and involved in the synthesis
of complex N-glycan structures (Damerow et al. 2014).
In this work, we apply the methodology previously described for
the analysis and phenotyping of GT mutants of T. brucei (Izquierdo,
Nakanishi, et al. 2009; Izquierdo et al. 2013), to biochemically char-
acterize another UDP-sugar-dependent GT, Tb927.2.3370 referred to
here as TbGT3.
Results
Creation and analysis of a bloodstream form TbGT3
conditional null mutant
We selected a putative GT (Tb927.2.3370) from T. brucei to determine
its activity by the creation and biochemical characterization of a condi-
tional null mutant under nonpermissive conditions. The gene encodes a
377 amino acid protein, with a theoretical mass of 43.7 kDa. A semi-
quantitative RT-PCR analysis previously performed over 21 full-length
ORFs encoding putative UPD-Gal- or UDP-GlcNAc-dependent GTs in
the T. brucei genome showed that the genewas present in both life cycle
stages of the parasite, but more highly expressed in procyclic form try-
panosomes (Izquierdo, Nakanishi, et al. 2009). This was conﬁrmed in a
recent quantitative proteomics study, which indicated that TbGT3 was
expressed ∼2.5-fold higher in procyclic form trypanosomes at the
protein level (Urbaniak et al. 2013).
The DXD sequence motif, common to many GTs (Wiggins and
Munro 1998) and probably involved in binding a divalent cation, is
present in the predicted protein as DDD, between amino acids 206
and 208. The protein has a predicted N-terminal transmembrane do-
main between residues 17–34 (Krogh et al. 2001) and is likely to be a
type II membrane protein, typical for Golgi apparatus GTs (Colley
1997). The Tb927.2.3370 gene and 5′ and 3′ untranslated ﬂanking
sequences were ampliﬁed with a high-ﬁdelity DNA polymerase from
T. brucei strain 427 genomic DNA. Four clones from four separate
PCR reactions were sequenced in both directions and the strain 427
sequence (Accession Number KF554011) was very similar to that in
the strain 927 genome database. In the ORF, there were four apparent
nucleotide polymorphisms and three of them produced amino acid
changes: his225 in place of Tyr225, Gln269 in place of Glu269 and
Arg301 in place of Gly301. The strain 427 gene and protein product
will be referred to from here as TbGT3 and TbGT3, respectively.
In order to analyze the function of the gene, we ﬁrst created con-
ditional null mutants in the bloodstream and procyclic forms of the
parasite. A preliminary Southern blot analysis using a TbGT3 ORF
probe suggested that there is a single copy of the gene per haploid
genome (Supplementary data, Figure S1), which was also consistent
with BLAST search of the T. brucei genome database with the
Tb927.2.3370 nucleotide sequence. Both T. brucei TbGT3 alleles
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were replaced in bloodstream form parasites and an ectopic inducible
copy of TbGT3 under tetracycline control was introduced. To gener-
ate the conditional null mutants, genetically modiﬁed bloodstream
form strains from 427 T. brucei containing a T7-RNA polymerase
and a tetracycline repressor under the control of a T7 promoter
were used (Wirtz and Clayton 1995). This cell line will be referred
to as “wild type” from here on.
The ﬁrst TbGT3 allele was replaced in the bloodstream form by
homologous recombination following electroporation of the parasites
in the presence of linear DNA containing the puromycin acetyltrans-
ferase (PAC) drug-resistance gene ﬂanked by ∼500 bp of TbGT3
5′- and 3′- untranslated region (UTR). Following selection with puro-
mycin, a ΔTbGT3::PACmutant was selected and transformed with an
ectopic, tetracycline-inducible, copy of TbGT3, introduced into the
ribosomal DNA locus under phleomycin selection (Wirtz et al.
1999). Then, maintaining tetracycline induction, the second endogen-
ous allele was replaced by an hygromycin phosphotransferase (HYG)
gene to yield the desired ΔTbGT3::PAC/TbGT3Ti/ΔTbGT3::HYG
bloodstream form mutant. Southern analysis conﬁrmed that both
endogenous TbGT3 gene copies were absent from the mutant
(Figure 1A). Northern blot showed that TbGT3 mRNA transcripts
were absent under nonpermissive conditions (i.e., with no tetracycline
added to the media) (Figure 1B). This and the normal in vitro growth
kinetics of the TbGT3 mutant in the absence of tetracycline (data not
shown) allows us to conclude thatTbGT3 encodes a nonessential gene
in bloodstream form T. brucei.
To observe any effects of the absence of TbGT3 activity on
T. brucei bloodstream-form glycosylation, wild-type and TbGT3 con-
ditional null-mutant variant surface glycoprotein 221 (VSG221) was
puriﬁed in a soluble form (Cardoso de Almeida and Turner 1983;
Ferguson et al. 1985) from cells grown in the presence and absence
of tetracycline for 48 h. Mature wild-type sVSG221 glycoprotein con-
tains twoN-glycosylation sites, one at Asn296 occupied by pauciman-
nose and small complex structures and another at Asn428 occupied by
oligomannose structures (Zamze et al. 1991), and a highly galactosy-
lated GPI anchor glycan (Mehlert, Richardson, et al. 1998; Mehlert,
Zitzmann, et al. 1998). Thus, we use the glycosylation status of
sVSG221 as a convenient reporter to assess any effects that a mutation
has on the formation of several glycosidic linkages (Jones et al. 2005;
Urbaniak et al. 2006;Manthri et al. 2008; Izquierdo et al. 2012). Ana-
lysis of the glycoform pattern of sVSG221 fromwild-type and TbGT3
conditional null-mutant cells, grown in the presence and absence of
tetracycline, by electrospray-mass spectrometry (ES-MS) did not
reveal any alterations in its glycosylation pattern (data not shown).
In order to analyze the high-molecular-weight branched poly
LacNAc-containing N-glycans of bloodstream form T. brucei (Atrih
et al. 2005), we performed SDS/urea extraction of total glycoproteins
from trypanosome ghosts (depleted of VSG) andwestern blotting with
lectins. The extracts of wild-type and conditional cells before and after
tetracycline induction were analyzed by ricin, which detects galactose
residues, and wheat germ agglutinin (WGA) blotting. In the case of the
ricin blot (data not shown), the patterns were similar to each other and
to previous ricin blots (Urbaniak et al. 2006; Manthri et al. 2008;
Stokes et al. 2008; Izquierdo, Nakanishi, et al. 2009). However, the
absence of TbGT3 activity due to nonpermissive conditions very
slightly decreased the binding of WGA (Figure 1C, see high-
molecular-weight species). WGA has complex-binding properties, in-
cluding binding to GlcNAcβ1-6Gal motifs (Muraki et al. 2002), which
are characteristic of branched poly-N-acetyllactoaminoglycans previ-
ously described in blood stream trypanosomes. Thus, the differences
observed suggest that the TbGT3 product may play a minor role in
the biosynthesis of branched poly-LacNAc structures in the blood-
stream form of the parasite.
Analysis of a procyclic form TbGT3 conditional null
mutant under nonpermissive conditions
In order to investigate if a more dramatic phenotype could be observed
in the procyclic form of the parasite, a TbGT3 conditional null mutant
was prepared in this stage of the parasite using cell line 29.13.6 (de-
rived from T. brucei strain 427), that retain genomic T7-RNA poly-
merase and TETR genes in presence of G418 and hygromycin
selection (Wirtz et al. 1999). The TbGT3 alleles were replaced using
the same targeting vectors used in the bloodstream form of the para-
site, but containing PAC and blasticidin S deaminase (BSD)
drug-resistance cassettes and an ectopic, tetracycline-inducible, copy
of TbGT3, introduced into the ribosomal DNA locus under phleomy-
cin selection increasing the number of TbGT3 genomic copies (Wirtz
et al. 1999). The glycosylation phenotype was assessed in this TbGT3
procyclic form conditional null mutant, ΔTbGT3::PAC/TbGT3Ti/
ΔTbGT3::BSD, after conﬁrmation by Southern blot that both
TbGT3 gene endogenous copies were absent in the mutant (Figure 2A).
As in the case of the bloodstream form, procyclic form conditional null
mutants were able to grow normally in vitro without the presence of
tetracycline in the media, showing that the gene is also nonessential in
the procyclic form of the parasite. Furthermore, mutants grown in
nonpermissive conditions were able to colonize the tsetse midgut,
Fig. 1. Characterization of TbGT3 bloodstream form conditional null mutant.
(A) Southern blot of genomic DNA from bloodstream form wild type (lane 1),
wild-type + TbGT3Ti (lane 2) and TbGT3 conditional null mutant (ΔTbGT3::PAC/
TbGT3Ti/ΔTbGT3::HYG) (Lane 3) digested with EcoRI and probed with TbGT3
ORF. The arrowheads indicate the bands corresponding to the endogenous
(End) and ectopic (Ect) copies of the TbGT3 gene. (B) Northern blot of total
RNA extracted from wild-type cells (lane 1) and the TbGT3 conditional null
mutant grown in absence (lane 2) or presence of tetracycline (lane 3) for
48 h, probed with the TbGT3 probe (upper panel) and the β-tubulin probe as
a control (lower panel). (C) Blot of total glycoprotein extracts of wild type
(lane 1), TbGT3 conditional null mutant minus Tet (lane 2) and TbGT3
conditional null mutant plus Tet (lane 3), incubated with WGA without
(upper panel) and with inhibitors (speciﬁcity control, middle panel), and
stained with pounceau (loading control, lower panel).
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although the infectivity wasmarginally reduced compared with that of
the wild type (Figure 2B). To assess the glycosylation phenotype of
procyclic form parasites, procyclins from wild-type and conditional
null mutant grown in the absence or presence of tetracyclin were ex-
tracted (Ferguson et al. 1993; Izquierdo et al. 2013) and analyzed by
SDS–PAGE and periodate-Schiff staining for carbohydrate. This re-
vealed a signiﬁcant reduction in the apparent molecular weights of
the TbGT3 null-mutant procyclins grown in the absence of tetracyc-
line in the media for 48 h compared with wild type and the mutant
grown in the presence of tetracycline (Figure 2C). Thus, the
reduction in procyclin apparent molecular weight is speciﬁcally due
to the lack of expression of the TbGT3 gene.
The procyclin polypeptides extracted from the TbGT3 mutant
cells in absence and presence of tetracyclinewere analyzed byMALDI-
ToF after aq. HF dephosphorylation with and without mild acid treat-
ment (Acosta-Serrano et al. 1999; Mehlert et al. 1999). The dual aq.
HF dephosphorylation with mild acid treatment cleaves off the GPI
anchors through dephosphorylation and cleaves the very acid-labile
Asp-Pro (DP) peptide bonds present on the N-terminal side of
EP-repeats of the EP-procyclins. This yields N-glycosylated peptide
fragments that are characteristic of the procyclin types being
expressed, in this case a mixture of EP3, EP1-2 and a trace of EP2
(Figure 3A). When the mild acid hydrolysis step is omitted, the frag-
ments generated by GPI anchor removal alone still contain the
N-glycosylated N-terminal domains of the procyclins (Figure 3B). In
this case, we can see ions corresponding to the EP3 and EP1-2 protein
components bearing Hex5HexNAc2 N-glycan structures (Acosta-
Serrano et al. 1999). Taken together, these analyses show that the re-
ductions in the apparent molecular weights of the TbGT3 conditional
null mutant grown in the absence of tetracycline were most likely due
to alterations in the structure of the GPI anchor side chains (Izquierdo,
Nakanishi, et al. 2009) since, upon GT3 deletion, the repertoire
of procyclin proteins and the size of their N-glycans remained
unchanged.
Characterization of the changes in the procyclin GPI
anchor side chain in the TbGT3 conditional null mutant
under nonpermissive conditions
In order to analyze the speciﬁc changes in procyclin GPI anchor side
chain structure induced by the lack of TbGT3 expression, procyclins
were isolated from wild-type and TbGT3 conditional null mutant
grown in the absence of tetracycline. GPI anchor glycans were released
from the procyclin peptide and the lyso-phosphatidic acid lipid com-
ponent of the PI moiety by aq. HF dephosphorylation (a procedure
that also removes some sialic acid residues). The released GPI glycans
were subsequently permethylated, a procedure that removes the fatty
acid from the inositol ring, methylates all free hydroxyl groups and
converts the amine group of the glucosamine residue to a positively
charged quaternary amine (Baldwin 2005; Mehlert and Ferguson
2007; Izquierdo, Nakanishi, et al. 2009; Nett et al. 2010). Analysis
of the permethylated GPI glycan fractions by positive ionMALDI-ToF
produced complex spectra (Figure 4). The [M]+ molecular ions in the
spectra can be accounted for by assuming core structures of Hex6-
HexN(Me3)
+Ino substituted with between zero and eight HexHex-
NAc units and with the presence of sialic acid residues in some cases
(Figure 4A). Although not a quantitative technique, the glycan species
from the TbGT3 conditional null mutant grown under nonpermissive
conditions appear to be signiﬁcantly smaller (Figure 4B). Series from
Hex5HexN(Me3)
+Ino, most probably from Hex6HexN(Me3)
+Ino los-
ing a terminal galactose residue, can also be observed in panels A and
B (see the open circles plus arrows).
The same permethylated GPI glycan samples were also analyzed
by positive ion ESI-MS and doubly charged [M+Na]2+ ions of (Hex-
NAc)Hex6HexN(Me3)
+Ino species were observed at m/z 994.51.
Fragmentation of these ions (MS2) produced an intense singly charged
product ion at m/z 1696.81, arising from elimination of the inositol
residue and quaternary amine group (Supplementary data
Figure S2), which on further fragmentation (MS3) produced the prod-
uct ion spectra shown in Figure 5. The spectra show differences in the
compositions of the isobaric permethylated glycans between the two
samples. The wild-type sample contains two principle components,
(HexNAc)Hex6HexN(Me3)
+Ino and (HexHexNAc)Hex5HexN(Me3)
+
Ino (Figure 5A), whereas the TbGT3 mutant only contains the
(HexNAc)Hex6HexN(Me3)
+Ino species (Figure 5B). These data strong-
ly suggest that TbGT3 encodes a Gal transferase that acts on the GPI
anchor side chain to add a Gal residue to the non-reducing-terminal
GlcNAc residue.
The same permethylated GPI glycan fractions were subjected to acid
hydrolysis, reduction and acetylation to provide partially methylated al-
ditol acetate derivatives (PMAAs) that were analyzed by GC–MS to
provide a methylation linkage analysis (Figure 6; Supplementary data,
Table S1). Normalizing the PMAA signals to the 6-O-substituted Man
residue of the conserved Man3GlcN-Ino core, we can see that the
TbGT3 mutant GPI glycan is deﬁcient in 3-O-substituted Gal residues
and does not contain any 3-O-substituted GlcNAc residues, whereas
wild-type GPI glycans contain both 4- and 3-O-substituted GlcNAc.
Thus, the methylation linkage data suggest that TbGT3 is a β1-3 Gal-
transferase that acts on one of the GlcNAc residues of the GPI anchor
side chain. Consistent with this, some non-reducing-terminal GlcNAc
(t-GlcNAc) is also apparent in the methylation linkage analysis
(Figure 6B). Interestingly, these are not the only changes of PMAAs
relative to 6-O-substituted Man; there are signiﬁcant increases in
Fig. 2. TbGT3 conditional null-mutant procyclic cells grown in the absence of
tetracycline are infective to tsetse ﬂies and express smaller procyclin
molecules than the wild type. (A) Southern blot of genomic DNA from
procyclic form wild type (lane 1), wild-type + TbGT3Ti (lane 2) and TbGT3
conditional null mutant (ΔTbGT3::PAC/TbGT3Ti/ΔTbGT3::HYG) (lane 3)
digested with HindIII and probed with TbGT3 ORF. The arrowheads indicate
the bands corresponding to the endogenous (End) and ectopic (Ect) copies
of the TbGT3 gene. (B) Teneral tsetse ﬂies were fed with bloodmeals
containing either wild-type or GT3 null mutants in the absence of
tetracycline (tet). After 22 days, the ﬂies (40 in each group) were dissected
and midgut infections scored as heavy (black; >100 trypanosomes/ﬁeld),
intermediate (dark gray; 20–100 trypanosomes/ﬁeld), weak (light gray; 1–19
trypanosomes/ﬁeld) or negative (no detectable cells). (C) Periodate-Schiff
stained SDS–PAGE gel of extracted procyclins from wild type (lane 1) and
TbGT3 mutant cells grown without tetracycline (lane 2) or with tetracycline
(lane 3).
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4-O-substituted GlcNAc and 3,6-di-O-substituted Gal residues, sug-
gesting that there may be some compensatory mechanism at work in
the absence of TbGT3 activity. This could include, for example, the
modiﬁcation of some of the βGlcNAc normally used as the acceptor
substrate by TbGT3 by a β1-4 Gal-transferase.
Discussion
The survival strategies of protozoan parasites frequently involve the
participation of glycoconjugates. In the particular case of T. brucei,
several precursors required for the biosynthesis of these glycoconju-
gates such as UDP-Gal and UDP-GlcNAc (Roper et al. 2002, 2005;
Stokes et al. 2008; Marino et al. 2011) are essential for the survival
of the parasite in the bloodstream and/or procyclic form life stages.
This prompted us to mine the T. brucei genome for
UDP-sugar-dependent GTs and to investigate their essentiality, func-
tion and speciﬁcity by the creation of null or conditional null mutants.
The fact that the TbGT3 conditional null-mutant cell lines grow nor-
mally in vitro in the absence of tetracycline in both the procyclic and
the blood stream form of the parasite, show that TbGT3 is non-
essential for the survival of T. brucei. Similarly, experiments carried
out in mice and tsetse ﬂies indicate that the gene is nonessential for
the survival of the parasite in vivo, though of course these types of ex-
periment generally fail to pick up subtle ﬁtness traits that can be suf-
ﬁcient to maintain the genes in nature.
Using awell-established workﬂow for the functional and biochem-
ical characterization of T. brucei GTs (Izquierdo, Nakanishi, et al.
2009; Izquierdo et al. 2013), we designate TbGT3 as primarily a
Fig. 3.MALDI-ToFmass spectra of procyclins from the TbGT3 conditional null mutant show no differences in procyclin polypeptide or N-glycosylation structure. (A)
MALDI-ToF mass spectra of aq. HF dephosphorylated and mild acid-treated procyclins from the TbGT3 conditional null mutant grown in absence (top panel) or
presence of tetracycline (bottom panel) for 48 h. (B) MALDI-ToF mass spectra of aq. HF dephosphorylated procyclins from the TbGT3 conditional null mutant
grown in absence (top panel) or presence of tetracycline (bottom panel) for 48 h. The diagnostic peptide ions (Acosta-Serrano et al. 1999) for the different types
of procyclins are indicated.
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GPI side chain modifying UDP-Gal : βGlcNAc β1-3 Gal-transferase.
However, like TbGT8, which is both a GPI side-chain modifying
UDP-GlcNAc:βGal β1-3 GlcNAc-transferase (Izquierdo, Nakanishi,
et al. 2009) and involved in large complex N-glycan synthesis in
bloodstream form parasites (Nakanishi et al. 2014), TbGT3 is likely
also to be involved in some way in the synthesis of large complex
N-glycans in the bloodstream form of the parasite (Atrih et al.
2005; Izquierdo, Nakanishi, et al. 2009).
With respect to the GPI anchor modifying activity of TbGT3, we
postulate that it acts on the product of TbGT8, either directly or after
the action of an unknown α1-3 Gal-transferase (Figure 7).
Materials and methods
Cultivation of trypanosomes
Bloodstream form T. brucei genetically modiﬁed to express T7 poly-
merase and the tetracycline repressor protein were cultivated inHMI-9
medium containing 2.5 μg mL−1 G418 at 37°C in a 5% CO2 incuba-
tor as described in Wirtz et al. (1999). Trypanosoma brucei procyclic
form parasites that maintain T7 polymerase and tetracycline repressor
protein under G418 and hygromycin selection (cell line 29:13) (Wirtz
et al. 1999) were cultured in SDM-79 medium at 28°C.
DNA isolation and manipulation
Plasmid DNAwas puriﬁed from Escherichia coli (DH5α) using Qiagen
Miniprep or Maxiprep kits, as appropriate. Gel extraction was per-
formed using Qiaquick kits. Custom oligonucleotides were obtained
from the Dundee University oligonucleotide facility. Trypanosoma
brucei genomic DNA was isolated from∼2 × 108 bloodstream form
cells or from 1 × 109 procyclic cells using DNAzol (Helena Biosciences).
Generation of constructs
The 413 bp 5′- and 401 bp 3′-UTR sequences next to the
Tb927.2.3370 ORF were PCR-ampliﬁed from genomic DNA using
Platinum Taq DNA polymerase HiFi (Invitrogen) with 5′-atgGCGG
CCGCgatgaggaaaggttgctgagtt-3′ and 5′-gtttaaacttacggaccgtcaagctt
tttccggatcgtatacctaaaac-3′ and 5′- gacggtccgtaagtttaaacggatcctttagg
ctccaattggtaaaag -3′ and 5′-gatGCGGCCGC gtaaacacacacgaga
aaacaaca-3′ as forward and reverse primers, respectively. The two
Fig. 4. MALDI-ToF mass spectra of permethylated GPI glycans isolated from wild type and TbGT3 conditional null-mutant trypanosomes grown in absence of
tetracycline. Permethylated glycans of the GPI anchors of wild type (A) and TbGT3 conditional null mutant grown in absence of tetracycline (B) were analyzed
by positive MALDI-ToF MS after co-crystallization with a 2,5-dihydroxybenzoic acid matrix. A series of GPI glycans with several Hex-HexNAc repeats are
indicated. Open circles show a similar series minus a terminal Hex residue, presumably attached to the mannose core (solid arrows indicate neutral losses of
204 Da, equivalent to one methylated hexose residue). Asterisks indicate molecules with sialic acid residues (up to three sialic acid residues can be detected in
the wild-type GPI anchors; dotted arrows indicate 361 Da mass increases, equivalent to methylated sialic acid residues).
6 L Izquierdo et al.
 by guest on February 6, 2015
http://glycob.oxfordjournals.org/
D
ow
nloaded from
 
PCR products were used together in a further PCR reaction to yield a
product containing the 5′-UTR linked to the 3′-UTR by a short Hin-
dIII and BamHI cloning site (underlined) and NotI restriction sites at
each end (capital letters). The PCR product was cloned into the NotI
site of the pGEM-5Zf(+) vector (Promega) and the HYG and PAC
drug-resistance genes were introduced into the targeting vector via
the HindIII and BamHI cloning sites. For re-expression of
Tb927.2.3370 the ORF was PCR ampliﬁed from genomic DNA
using Platinum Taq DNA polymerase HiFi with 5′-cgcAAGCTT
atggtgtcgaagggtttac-3′ and 5′-cgcGGATCCtcagcatttcccacgagc-3′ and
cloned into the pLew100 vector (Wirtz et al. 1999) cut with HindIII
and BamHI, to generate pLewGT3. This plasmid was then digested
with NotI, and puriﬁed for transfection.
Transformation of bloodstream and procyclic
form T. brucei
Constructs for gene replacement and ectopic expression were puriﬁed
using the Qiagen Maxiprep kit, digested with NotI to linearize, preci-
pitated and washed twice with 70% ethanol and re-dissolved in sterile
water. Cell culture and transformation were carried out as previously
described (Wirtz et al. 1999; Milne et al. 2001).
Southern and Northern blotting
Aliquots of genomic DNA isolated from T. brucei cultures were di-
gested with various restriction enzymes. Fluorescein-labelled probes
were generated using the CDP-star random prime labelling kit
(Gene Images); 250 ng of template was used in a reaction volume of
50 μL and incubated for 90 min. Aliquots of 5 μL were used for
each Southern blot experiment.
Total RNA for Northern blots was prepared using Qiagen RNeasy
Midi kits. Samples of RNA (5 μg) were run on formaldehyde-agarose
gels and transferred to Hybond N nylon membrane (Amersham Bios-
ciences) for hybridization with [α-32P]-dCTP-labeled T. brucei
Tb927.2.3370 probe (Stratagene, Prime-It RmT random primer label-
ling kit). The control β-tubulin probewas used after the Tb927.2.3370
probe had decayed.
Tsetse ﬂy infections
Tsetse ﬂy infections were carried out as described in Guther et al.
(2006). Pupae of Glossina morsitans morsitans were obtained from
Institute of Zoology, Slovak Academy of Science (Bratislava, Slovakia)
andmaintained at theWCMP tsetse ﬂy facility, University of Glasgow.
Newly hatched (teneral) ﬂies were fed with an infected bloodmeal,
which consisted of 107 parasites mixed with washed deﬁbrinated
horse blood (containing 10% fetal bovine serum). Infected ﬂies were
fed with bloodmeals every 2–3 days. After 2 weeks or 3 weeks, mid-
guts were isolated from infected ﬂies and disrupted by mechanical
force in cold SDM-79 containing 10% fetal bovine serum. Isolated
parasites from individual midguts were kept on ice until counted on
an hemocytometer.
Fig. 5.MS3 product ion spectra of permethylated GPI glycans show the presence of a terminal Hex-HexNAc unit in thewild type and a terminal HexNAc in the TbGT3
conditional null mutant grown in absence of tetracycline. Permethylated glycans of the GPI anchors of wild type (A), TbGT3 conditional null mutant grown in
absence tetracycline (B) were analyzed by positive ESI-MS. Doubly charged [M+Na]2+ ions observed at m/z 994.51 were fragmented (MS2) generating a singly
charged daughter ion at m/z 1697.99. This ion was further fragmented (MS3) to generate the product ion spectra shown in the ﬁgure. Assignments of the
diagnostic ions are indicated on the inset diagrams. The product ion at m/z 1437 is diagnostic of the presence of a t-GlcNAc in the Hex6HexN(Me3)+Ino core
structure (both panels), whereas the product ion at m/z 1233 (only in panel A) is diagnostic of the presence of a HexHexNAc unit attached to a Hex5HexN
(Me3)+Ino core. The key is the same as in Figure 4.
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Puriﬁcation of procyclins
Procyclins (both GPEET and EP forms) were puriﬁed from 1011 freeze
dried trypanosomes by organic solvent extraction followed by octyl-
Sepharose chromatography (Amersham Pharmacia Biotech) (Ferguson
et al. 1993; Treumann et al. 1997; Mehlert et al. 1999). For some
speciﬁc procedures, such as SDS–PAGE and periodate-Schiff stain,
procyclins were extracted from batches of ∼1 × 108 cells and were run
directly with the extracts without prior puriﬁcation by octyl-Sepharose
chromatography.
Analysis by MALDI-ToF MS
Approximately 250 pmol of octyl-Sepharose-puriﬁed procyclins deter-
mined byGC–MS (Ferguson 1994) was dried and treated with 50 μL of
ice-cold 50% aqueous hydrogen ﬂuoride for 24 h at 0°C to cleave the
GPI anchor ethanolamine-phosphate bond. Some preparations were
further treated with 50 μL of 40 mM triﬂuoroacetic acid, 100°C for
20 min to cleave Asp-Pro bonds and remove N-glycosylated N termini
(Acosta-Serrano et al. 1999). The samples were dried and re-dissolved
in 5 μL of 0.1% triﬂuoroacetic acid. Aliquots (1 μL) of each sample
were mixed with 1 μL of 10 mg mL−1 sinapinic acid in 50%
acetonitrile, 0.1% triﬂuoroacetic acid and analyzed by positive ion
MALDI-ToF. Data collection was in linear mode on a Voyager-DE
STR instrument. The accelerating voltage was 25,000 V, and grid volt-
age was set at 94% with an extraction time delay of 700 ns. Data were
collected manually at 500 shots/spectrum with the laser intensity set at
2500. The analysis of the native procyclins (500 pmol/sample) was per-
formed in negative mode using sinapinic acid as the matrix. For the
analysis of the permethylated GPI glycans, the instrument was set in
reﬂectron mode, positive ion and a matrix of 2,5-dihydroxybenzoic
acid (15 mg mL−1 in 0.5% TFA) was used.
Permethylation and ES-MS of GPI glycans
Samples were dried and permethylated by the sodium hydroxide and
methyl iodide method, as described in Ferguson (1994). The per-
methylated glycans were dissolved in 50 μL of 80% acetonitrile, and
aliquots (5 μL) were dried and recovered in 80% acetonitrile, 0.5 mM
sodium acetate before loading into nanotips (Micromass type F) for
positive ion ES-MS, ES-MS2 and ES-MS3 on an LTQ Orbitrap
Velos mass spectrometer (Thermo Scientiﬁc). Source and capillary vol-
tages were 0.63 kV and 48 V, respectively, and the collision energy
was 17–19%.
Methylation linkage analysis by GC–MS
The remainder of the permethylated glycan samples were subjected to
acid hydrolysis, NaB2H4 reduction and acetylation (to yield PMAAs),
and analyzed by GC–MS as described in Ferguson (1994). The
PMAAs were analyzed on an Agilent 6890 N GC–MS system ﬁtted
with an HP-5 column.
Lectin blotting of T. brucei cell extracts
Bloodstream form T. brucei cells were washed twice in trypanosome
dilution buffer (5 mM KCl, 80 mM NaCl, 1 mM MgSO4, 20 mM
Na2HPO4, 2 mM NaH2PO4, 20 mM glucose, pH 7.4), solubilized
Fig. 6. GC–MS linkage analysis of permethylated GPI glycans reveals differences between the wild type and the TbGT3 conditional null mutant grown under
nonpermissive conditions. Permethylated glycans of the GPI anchors of wild type (A) and TbGT3 conditional null mutant grown in absence of tetracycline (B)
were acid hydrolyzed, reduced, acetylated and the resulting PMAA derivatives were analyzed by GC–MS to produce the total ion chromatograms shown. The
peak marked scyllo-inositol is an internal standard of scyllo-inositol hexa-acetate. The peak marked with an asterisk is a reagent artefact. The PMAA peaks are
annotated according to the original substitution pattern of the native glycans. For example, t-Man refers to non-reducing-terminal mannose and 3-Man refers to
3-O-substituted mannose (see Supplementary data Table S1). The peak marked t-GlcNAc* in (B) is a mixture of t-GlcNAc PMMA and non-sugar contaminant.
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with 2% SDS and 4 M urea, subjected to SDS–PAGE and transferred
to nitrocellulose membranes (Amersham Biosciences). The mem-
branes were incubated for 1 h with biotin-conjugated ricin (Vector
Labs) diluted 1/3000, with or without inhibitors (10 mg mL galactose
and 10 mg mL lactose) or 1 h with biotin-conjugated WGA (Vector
Laboratories) diluted 1/2000, with or without inhibitor (1/10 Chitin
hydrolysate). Membranes were then incubated for 1 h with
extravidin-HRP diluted 1/10000, and developed with ECL (Amer-
sham Biosciences) according to the manufacturer’s instructions.
Supplementary data
Supplementary data for this article are available online at http://glycob.
oxfordjournals.org/.
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